Eli Lilly Price to Sales Ratio 2006-2019 | LLY

Historical PS ratio values for Eli Lilly (LLY) over the last 10 years. The current P/S ratio for Eli Lilly as of October 18, 2019 is .
Eli Lilly P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2019-10-18 108.64 4.37
2019-06-30 110.79 $24.86 4.46
2019-03-31 129.76 $24.19 5.36
2018-12-31 115.11 $23.74 4.85
2018-09-30 106.20 $21.91 4.85
2018-06-30 83.98 $21.36 3.93
2018-03-31 75.62 $21.45 3.53
2017-12-31 81.96 $21.67 3.78
2017-09-30 82.48 $21.24 3.88
2017-06-30 78.85 $20.78 3.79
2017-03-31 80.07 $20.37 3.93
2016-12-31 69.55 $19.99 3.48
2016-09-30 75.41 $19.61 3.84
2016-06-30 73.52 $19.37 3.79
2016-03-31 66.78 $18.95 3.52
2015-12-31 77.60 $18.73 4.14
2015-09-30 76.60 $18.45 4.15
2015-06-30 75.96 $18.33 4.14
2015-03-31 65.65 $18.24 3.60
2014-12-31 61.90 $18.24 3.39
2014-09-30 57.76 $18.83 3.07
2014-06-30 54.93 $19.62 2.80
2014-03-31 51.59 $20.50 2.52
2013-12-31 44.29 $21.28 2.08
2013-09-30 43.29 $21.26 2.04
2013-06-30 41.88 $20.79 2.01
2013-03-31 47.99 $20.33 2.36
2012-12-31 41.30 $20.25 2.04
2012-09-30 39.29 $20.34 1.93
2012-06-30 35.16 $21.00 1.67
2012-03-31 32.61 $21.61 1.51
2011-12-31 33.24 $21.81 1.52
2011-09-30 29.18 $21.98 1.33
2011-06-30 29.22 $21.58 1.35
2011-03-31 27.04 $21.17 1.28
2010-12-31 26.56 $20.89 1.27
2010-09-30 27.31 $20.70 1.32
2010-06-30 24.71 $20.65 1.20
2010-03-31 26.35 $20.27 1.30
2009-12-31 25.61 $19.89 1.29
2009-09-30 23.36 $19.25 1.21
2009-06-30 24.14 $18.94 1.27
2009-03-31 22.96 $18.83 1.22
2008-12-31 27.31 $18.62 1.47
2008-09-30 29.43 $18.62 1.58
2008-06-30 30.56 $18.07 1.69
2008-03-31 33.82 $17.61 1.92
2007-12-31 34.68 $17.09 2.03
2007-09-30 36.68 $16.24 2.26
2007-06-30 35.74 $15.59 2.29
2007-03-31 34.10 $14.90 2.29
2006-12-31 32.82 $14.44 2.27
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $104.711B $24.556B
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $359.375B 15.53
Roche Holding AG (RHHBY) Switzerland $250.381B 0.00
Merck (MRK) United States $214.559B 17.64
Pfizer (PFE) United States $201.662B 11.88
Novartis AG (NVS) Switzerland $199.914B 17.20
Novo Nordisk (NVO) Denmark $124.746B 22.04
Sanofi (SNY) France $116.442B 14.31
AstraZeneca (AZN) United Kingdom $115.787B 22.40
AbbVie (ABBV) United States $111.093B 8.90
GlaxoSmithKline (GSK) United Kingdom $105.929B 13.31
Bristol-Myers Squibb (BMY) United States $85.747B 12.16
Bayer (BAYRY) Germany $68.188B 9.93
H Lundbeck (HLUYY) Denmark $6.714B 9.69